This site is intended for healthcare professionals
Drug information

Dasatinib Zentiva 80 mg film-coated tablets

Read time: 44 mins
Last updated: 24 Sep 2020
Published: 24 Sep 2020

4.1 Therapeutic indications

Dasatinib Zentiva is indicated for the treatment of adult patients with:

• Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL).

Dasatinib Zentiva is indicated for the treatment of paediatric patients with:

• newly diagnosed Ph+ ALL in combination with chemotherapy.

Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.




The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC ( Medthority offers the whole library of SPC documents from eMC.

Medthority will not be held liable for explicit or implicit errors, or missing data.

Reporting of suspected adverse reactions 

Drug Licencing

Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).